<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01775176</url>
  </required_header>
  <id_info>
    <org_study_id>PBRC 11016-A</org_study_id>
    <nct_id>NCT01775176</nct_id>
  </id_info>
  <brief_title>Effect of Weight &amp; Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle &amp; Adipose</brief_title>
  <acronym>PULSE-A</acronym>
  <official_title>Effect of Weight and Insulin Sensitivity on Reproductive Function in Polycystic Ovary Syndrome: Studies in Skeletal Muscle and Adipose Tissue 'PULSE Ancillary Study'</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this ancillary study is to obtain skeletal muscle and subcutaneous&#xD;
      adipose tissue biopsies from women with polycystic ovary syndrome enrolled in the PULSE Study&#xD;
      (NCT01482286).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscle and adipose tissues will be appropriately collected and banked for future studies such&#xD;
      as to measure expression of candidate genes involved with carbohydrate and fat oxidation and&#xD;
      mitochondrial function by RT-PCR, protein content by western blot, enzyme activity by&#xD;
      enzymatic assays and to perform functional studies under varying conditions (for example&#xD;
      before and after treatment with insulin, testosterone, serum) to quantify insulin signaling&#xD;
      and carbohydrate and fat oxidation in primary human cultures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Parent Study stopped due to poor recruitment and enrollment&#xD;
  </why_stopped>
  <start_date type="Actual">May 2012</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bio specimens for future research</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">17</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>Polycystic Ovary Syndrome</arm_group_label>
    <description>Overweight women with polycystic ovary syndrome. 20 - 40 years, inclusiveBody mass index ≥ 25kg/m2History of irregular menstrual cycles (fewer than 8 regular cycles in the past year)Clinical and/or biochemical androgen excess (Free androgen index&gt;3.85 and/or hirsuitism rating ≥8)Anovulatory menstrual cycles (determined during screening)</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Skeletal Muscle Subcutaneous Adipose Tissue&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Overweight women with polycystic ovary syndrome.&#xD;
&#xD;
        20 - 40 years, inclusive Body mass index ≥ 25kg/m2 History of irregular menstrual cycles&#xD;
        (fewer than 8 regular cycles in the past year) Clinical and/or biochemical androgen excess&#xD;
        (Free androgen index&gt;3.85 and/or hirsuitism rating ≥8) Anovulatory menstrual cycles&#xD;
        (determined during screening)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Enrolled in PULSE NCT01482286&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Withdraw from PULSE NCT01482286&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leanne M Redman, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 22, 2013</study_first_submitted>
  <study_first_submitted_qc>January 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2013</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Leanne Redman</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>PCOS, Weight, Insulin Sensitivity, Reproductive Function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

